Stockhub

Calithera Biosciences, Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

12 August 2022

3 August 2022

  • curprev 10:0110:01, 3 August 2022‎ Chris talk contribs‎ 1,507 bytes +1,507‎ Created page with "Calithera Biosciences, Inc., a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule compounds for tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. The company offers INCB001158, an orally bioavailable arginase inhibitor of arginase that is in Phase 1/2 clinical trial for the treatment of hematology and oncology. It is developing CB-280, an oral arginase inhibitor that has comp..." Tag: Visual edit
Retrieved from ‘https://stockhub.co/research/Calithera_Biosciences,_Inc.’